NCT03332264已完成不适用
Sequent Please Drug Coated Balloons Versus Primary Stent Application in Long SFA Lesions
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- InnoRa GmbH
- 入组人数
- 224
- 试验地点
- 10
- 主要终点
- Percent diameter stenosis at 1 year post intervention in successfully treated patients
研究概览
简要总结
Patients with peripheral artery disease will be treated with either drug coated balloon catheter, drug coated stent or uncoated stent.
详细描述
Patients with chronic stenotic or occlusive atherosclerotic disease and lesions of at least 13 cm length in the SFA or Arteria poplitea segment 1 will be randomized to either treatment with paclitaxel coated balloon catheter, paclitaxel coated stent or bare nitinol stent. Vessel patency will be evaluated by quantitative angiography after 12 months. Clinical follow-ups will be done until 36 months post-intervention.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- None
盲法说明
Corelab will be masked for the bare metal and paclitaxel coated stent arm.
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •PAOD and Rutherford classes 2 - 4 (pain-free walking distance <500 m)
- •eligible for peripheral revascularization by means of PTA
- •peripheral lesions in the superficial femoral artery (SFA) and / or the PI-segment of the popliteal artery (A.pop.)
- •minimum diameter stenosis of ≥70%
- •treatment length at least 15 cm (lesion length at least 13 cm)
- •maximum of lesions to be treated should be 2 (all treated lesions should be treated within the randomization to the study group, i.e. either coated balloon catheters or coated stents or bare nitinol stents); in case of two lesions matching the eligibility criteria, the one presenting the worst attributes (length and stenosis degree) should be chosen as target lesion
- •long diffuse stenosis with or without occlusions may only be divided in separate lesions if non-stenotic (i.e. <50% stenosis) segments in between the lesions extent to >2 cm, otherwise vessel segments will be treated as a single extended lesion
- •eligible for an operative vascular intervention in case of complications during the PTA
排除标准
- •Rutherford class 1,5 or 6
- •more than two stenotic lesions in the target vessel requiring treatment
- •inflow lesion (proximal to the study lesion) with flow limitation not being successfully treated prior to the study lesion
- •in-stent restenosis of the study lesion
- •strongly calcified lesions with circumferential presence of calcifications and a lesion calcification length of >4 cm
- •reference vessel diameter <4 mm and >6 mm
- •guide wire could not be successfully advanced across the lesion
- •lesions below the knee requiring treatment
- •target lesion is located in the PII-segment of the popliteal artery (A.pop.) or within a bypass graft
- •acute thrombosis of the study lesion requiring lysis or thrombectomy prior to the treatment of the study lesion
- •potential loss of leg due to critical or acute ischemia
- •no patent distal run-off vessel
- •medical reason against double anti-platelet therapy in anti-coagulated patient, e.g., receiving coumarine or conditions which prevent the intake of the double anti-platelet therapy for two months
- •female patient who is pregnant or lactating
- •under 18 years of age
- •patients under administrative or judicial custody (§20 Act on medical Devices, Germany)
- •expected life span of less than 24 months
结局指标
主要结局
Percent diameter stenosis at 1 year post intervention in successfully treated patients
时间窗: 12 +/- 2 months
by quantitative angiography
次要结局
- Late Lumen Loss(12 months)
- Binary restenosis(6,12, 24, 36 months)
- Target lesion revascularization(6, 12, 24, 36 months)
研究者
研究点 (10)
Loading locations...
相似试验
Unknown
不适用
Yao Strategy for the Treatment of de Novo Medina 0,1,0 or 0,0,1 Bifurcation LesionBifurcation LesionCoronary Artery DiseaseNCT06166459Xuzhou Third People's Hospital200
Unknown
不适用
BIO REsponse Adapted Combination Therapy Pilot StudyPeripheral Arterial DiseaseNCT03547986Biotronik AG150
尚未招募
不适用
Biolimus-Coated Balloon in de Novo Large Vessel Coronary LesionsCoronary Arterial Disease (CAD)NCT06669793Xuzhou Third People's Hospital475
招募中
不适用
Drug-Coated Balloon Versus Drug-Eluting Stent in Patient With ST-Segment Elevation Myocardial InfarctionNCT06742125Second Affiliated Hospital, School of Medicine, Zhejiang University1,244
Unknown
不适用
Α Pre CE-Marking Study Using the Rontis Drug Coated Balloon for Treatment of Lesions in Femoropopliteal ArteriesPeripheral Artery Disease (PAD)NCT04821388Rontis Hellas SA30